Spruce Biosciences Inc's Comment on Sales, Marketing and Customers
The company serves customers who bill federal programs for products, including federal healthcare benefit programs, private third-party payors, Medicaid, Medicare, and the Children’s Health Insurance Program. Its recipients of payments or transfers of value from manufacturers include healthcare professionals such as physicians (doctors, dentists, optometrists, podiatrists, and chiropractors), physician assistants, nurse practitioners, and teaching hospitals. The markets served encompass federal and state healthcare programs and providers subject to federal and state regulations concerning healthcare fraud, privacy, and security.
In recent years, major depressive disorder (MDD) has emerged as a prevalent and debilitating mental health condition worldwide. With a significant unmet medical need for effective therapies, pharmaceutical companies have been focusing their efforts on developing novel treatments. In this regard, Spruce Biosciences, Inc. (Spruce), a leading bio-pharmaceutical company dedicated to addressing unmet medical needs in endocrine and neurological disorders, has announced a strategic collaboration with HMNC Brain Health GmbH (HMNC). This collaboration aims to develop Spruce s investigational product candidate, tildacerfont, an antagonist of the receptor that plays a pivotal role in MDD.Background on Major Depressive ...
: Recent advancements in the treatment of polycystic ovary syndrome (PCOS) have unveiled novel therapeutic possibilities with the presentation of Phase 2 POWER study results by Spruce Biosciences, Inc. This article critically examines the efficacy and safety of tildacerfont, a second-generation CRF1 receptor antagonist, for PCOS, with findings introduced at the 2024 Annual Meeting of the Endocrine Society (ENDO 2024). PCOS is a prevalent endocrine disorder that affects an estimated 6-10% of women of reproductive age globally. Characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovaries, PCOS remains a significant challenge in medical management due to its complex etiology and variable pr...
Spruce Biosciences Inc’s Comment on Sales, Marketing and Customers
The company serves customers who bill federal programs for products, including federal healthcare benefit programs, private third-party payors, Medicaid, Medicare, and the Children’s Health Insurance Program. Its recipients of payments or transfers of value from manufacturers include healthcare professionals such as physicians (doctors, dentists, optometrists, podiatrists, and chiropractors), physician assistants, nurse practitioners, and teaching hospitals. The markets served encompass federal and state healthcare programs and providers subject to federal and state regulations concerning healthcare fraud, privacy, and security.
Sources:
Spruce Biosciences Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Spruce Biosciences Inc’s corporate clients.
For your research, we’ve provided 9 tables on Spruce Biosciences Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
